GreyBird Ventures is a venture capital that invests in medical technology firms that develop products for precision medicine. The firm was founded in 2013, in Concord, Massachusetts, United States.
GreyBird Ventures is interested in companies that provide molecular diagnosis, remote imaging diagnostics, life sciences, and mobile life solutions. The firm looks to be a lead investor during investments. The firm has invested seed and series A in companies such as Atlas5D, Ceres Nanosciences, Jiufeng Medical, and GNA Biosolutions.